Insider Buy/Sell Details for the Biotechnology Industry — April 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1153)
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
690
Price
$568.79
Total Value
$392.47K
Shares Held After
46,082
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,403
Price
$567.55
Total Value
$796.27K
Shares Held After
46,772
% of Holdings
2.9%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,629
Price
$566.66
Total Value
$923.10K
Shares Held After
48,175
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
543
Price
$565.66
Total Value
$307.15K
Shares Held After
49,804
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,115
Price
$564.55
Total Value
$629.48K
Shares Held After
50,347
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
371
Price
$563.58
Total Value
$209.09K
Shares Held After
51,462
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
774
Price
$562.34
Total Value
$435.25K
Shares Held After
51,833
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
351
Price
$561.69
Total Value
$197.15K
Shares Held After
52,607
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
514
Price
$560.30
Total Value
$287.99K
Shares Held After
52,958
% of Holdings
1.0%
IONIS PHARMACEUTICALS INC (IONS)
Devers Shannon L. — EVP, Chief Human Resources Ofc
Shares
6,193
Price
$74.05
Total Value
$458.61K
Shares Held After
16,348
% of Holdings
27.5%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$14.60
Total Value
$278.28K
Shares Held After
447,202
% of Holdings
4.1%
Nurix Therapeutics, Inc. (NRIX)
Ring Christine — Chief Legal Officer
Shares
8,148
Price
$15.24
Total Value
$124.15K
Shares Held After
26,453
% of Holdings
23.5%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
4,200
Price
$64.89
Total Value
$272.53K
Shares Held After
767,780
% of Holdings
0.5%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
15,800
Price
$64.06
Total Value
$1.01M
Shares Held After
771,980
% of Holdings
2.0%
Lipocine Inc. (LPCN)
Patel Mahesh V. — Director
Shares
25,000
Price
$2.02
Total Value
$50.50K
Shares Held After
135,679
% of Holdings
18.4%
Sensei Biotherapeutics, Inc. (SNSE)
MILLENNIUM MANAGEMENT LLC — 10% Owner
Shares
46
Price
$34.75
Total Value
$1.60K
Shares Held After
147,731
% of Holdings
0.0%
Sensei Biotherapeutics, Inc. (SNSE)
MILLENNIUM MANAGEMENT LLC — 10% Owner
Shares
1,104
Price
$31.52
Total Value
$34.80K
Shares Held After
147,731
% of Holdings
0.7%
Sensei Biotherapeutics, Inc. (SNSE)
MILLENNIUM MANAGEMENT LLC — 10% Owner
Shares
3,401
Price
$35.46
Total Value
$120.58K
Shares Held After
147,731
% of Holdings
2.3%
Sensei Biotherapeutics, Inc. (SNSE)
MILLENNIUM MANAGEMENT LLC — 10% Owner
Shares
1,613
Price
$34.59
Total Value
$55.79K
Shares Held After
147,731
% of Holdings
1.1%
Sensei Biotherapeutics, Inc. (SNSE)
MILLENNIUM MANAGEMENT LLC — 10% Owner
Shares
1,161
Price
$31.53
Total Value
$36.61K
Shares Held After
147,731
% of Holdings
0.8%
Beam Therapeutics Inc. (BEAM)
Evans John M. — Director
Shares
30,078
Price
$24.58
Total Value
$739.32K
Shares Held After
1,047,205
% of Holdings
2.8%
Beam Therapeutics Inc. (BEAM)
Simon Amy — Chief Medical Officer
Shares
6,700
Price
$24.58
Total Value
$164.69K
Shares Held After
102,735
% of Holdings
6.1%
Beam Therapeutics Inc. (BEAM)
Ciaramella Giuseppe — President
Shares
11,810
Price
$24.58
Total Value
$290.29K
Shares Held After
218,406
% of Holdings
5.1%
Beam Therapeutics Inc. (BEAM)
Cavanagh Bethany J — SVP, Finance and Treasurer
Shares
3,242
Price
$24.58
Total Value
$79.69K
Shares Held After
51,171
% of Holdings
6.0%
Beam Therapeutics Inc. (BEAM)
Bellon Christine — Chief Legal Officer
Shares
5,956
Price
$24.58
Total Value
$146.40K
Shares Held After
109,711
% of Holdings
5.1%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
1,300
Price
$49.98
Total Value
$64.97K
Shares Held After
97,994
% of Holdings
1.3%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
6,200
Price
$49.21
Total Value
$305.10K
Shares Held After
99,294
% of Holdings
5.9%
Spyre Therapeutics, Inc. (SYRE)
Sloan Sheldon — Chief Medical Officer
Shares
7,958
Price
$50.00
Total Value
$397.90K
Shares Held After
0
% of Holdings
100.0%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
2,656
Price
$49.92
Total Value
$132.59K
Shares Held After
627,540
% of Holdings
0.4%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
12,344
Price
$49.20
Total Value
$607.32K
Shares Held After
630,196
% of Holdings
1.9%
Apogee Therapeutics, Inc. (APGE)
Dambkowski Carl — Chief Medical Officer
Shares
100
Price
$85.89
Total Value
$8.59K
Shares Held After
208,398
% of Holdings
0.0%
Apogee Therapeutics, Inc. (APGE)
Dambkowski Carl — Chief Medical Officer
Shares
2,702
Price
$85.33
Total Value
$230.56K
Shares Held After
208,498
% of Holdings
1.3%
Apogee Therapeutics, Inc. (APGE)
Dambkowski Carl — Chief Medical Officer
Shares
2,698
Price
$84.31
Total Value
$227.47K
Shares Held After
211,200
% of Holdings
1.3%
Apogee Therapeutics, Inc. (APGE)
Henderson Jane — Chief Financial Officer
Shares
1,100
Price
$85.46
Total Value
$94.01K
Shares Held After
177,371
% of Holdings
0.6%
Apogee Therapeutics, Inc. (APGE)
Henderson Jane — Chief Financial Officer
Shares
900
Price
$84.46
Total Value
$76.01K
Shares Held After
178,471
% of Holdings
0.5%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
40
Price
$779.71
Total Value
$31.19K
Shares Held After
17,603
% of Holdings
0.2%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
4
Price
$778.24
Total Value
$3.11K
Shares Held After
17,643
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
9
Price
$777.42
Total Value
$7.00K
Shares Held After
17,647
% of Holdings
0.1%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
13
Price
$776.62
Total Value
$10.10K
Shares Held After
17,656
% of Holdings
0.1%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
14
Price
$775.58
Total Value
$10.86K
Shares Held After
17,669
% of Holdings
0.1%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
8
Price
$774.58
Total Value
$6.20K
Shares Held After
17,683
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
8
Price
$773.59
Total Value
$6.19K
Shares Held After
17,691
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
3
Price
$772.76
Total Value
$2.32K
Shares Held After
17,699
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
1
Price
$771.32
Total Value
$771.32
Shares Held After
17,702
% of Holdings
0.0%
BioAge Labs, Inc. (BIOA)
RUBIN PAUL D — Chief Medical Officer
Shares
8,820
Price
$17.81
Total Value
$157.08K
Shares Held After
0
% of Holdings
100.0%
Vaxcyte, Inc. (PCVX)
Wassil Jim — CHIEF OPERATING OFFICER
Shares
838
Price
$58.93
Total Value
$49.39K
Shares Held After
162,994
% of Holdings
0.5%
Vaxcyte, Inc. (PCVX)
Wassil Jim — CHIEF OPERATING OFFICER
Shares
1,412
Price
$58.14
Total Value
$82.09K
Shares Held After
165,406
% of Holdings
0.8%
INSMED Inc (INSM)
Adsett Roger — Chief Operating Officer
Shares
62,344
Price
$164.95
Total Value
$10.28M
Shares Held After
106,810
% of Holdings
36.9%
INSMED Inc (INSM)
Adsett Roger — Chief Operating Officer
Shares
19,001
Price
$164.11
Total Value
$3.12M
Shares Held After
169,154
% of Holdings
10.1%
INSMED Inc (INSM)
Adsett Roger — Chief Operating Officer
Shares
6,715
Price
$163.18
Total Value
$1.10M
Shares Held After
188,155
% of Holdings
3.4%
Showing 201–250 of 1153 transactions (page 5 of 24)